Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-069192
Filing Date
2015-02-27
Accepted
2015-02-27 15:02:11
Documents
13
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d844845d10k.htm 10-K 1286830
2 EX-10.33 d844845dex1033.htm EX-10.33 15985
3 EX-23.1 d844845dex231.htm EX-23.1 2153
4 EX-31.1 d844845dex311.htm EX-31.1 7502
5 EX-31.2 d844845dex312.htm EX-31.2 7256
6 EX-32.1 d844845dex321.htm EX-32.1 7059
13 GRAPHIC g844845g75b19.jpg GRAPHIC 83323
  Complete submission text file 0001193125-15-069192.txt   8380092

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT orex-20141231.xml EX-101.INS 1076228
8 XBRL TAXONOMY EXTENSION SCHEMA orex-20141231.xsd EX-101.SCH 67690
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orex-20141231_cal.xml EX-101.CAL 73267
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orex-20141231_def.xml EX-101.DEF 394442
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE orex-20141231_lab.xml EX-101.LAB 570425
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orex-20141231_pre.xml EX-101.PRE 453786
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33415 | Film No.: 15657651
SIC: 2834 Pharmaceutical Preparations